Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc Reg S (HSM-S.TO)

Helius Medical Technologies Inc Reg S (HSM-S.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 178,843
  • Shares Outstanding, K 91,247
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade HSM-S.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.18
  • Most Recent Earnings $-0.04 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.90 +4.21%
on 04/24/17
2.01 -1.49%
on 04/27/17
-0.02 (-1.00%)
since 03/23/17
3-Month
1.75 +13.14%
on 02/09/17
2.35 -15.74%
on 03/03/17
-0.22 (-10.00%)
since 01/23/17
52-Week
0.95 +108.42%
on 08/16/16
2.35 -15.74%
on 03/03/17
+0.70 (+54.69%)
since 04/28/16

Most Recent Stories

More News
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference

NEWTOWN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors

NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
LIVN : 54.87 (-1.91%)
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

NEWTOWN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke

NEWTOWN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

NEWTOWN, Pa., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness,...

HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

NEWTOWN, Pa., July 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.53 (-6.02%)
HSM.TO : 18.35 (-1.71%)
JNJ : 146.44 (-1.41%)
TEVA : 13.06 (+0.38%)
BMY : 45.04 (-7.82%)

Business Summary

Helius Medical Technologies Inc is a medical technology company. It is focused on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company has developed its first, known as the portable neuromodulation stimulator or PoNS, device, is designed to enhance...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 2.02
1st Resistance Point 2.00
Last Price 1.98
1st Support Level 1.96
2nd Support Level 1.94
3rd Support Level N/A

See More

52-Week High 2.35
Last Price 1.98
Fibonacci 61.8% 1.82
Fibonacci 50% 1.65
Fibonacci 38.2% 1.48
52-Week Low 0.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar